Last updated on February 2020

A Study of NKTR-214 in Combination With Nivolumab Compared With the Investigator's Choice of a Tyrosine Kinase Inhibitor (TKI) Therapy (Either Sunitinib or Cabozantinib Monotherapy) for Advanced Metastatic Renal Cell Carcinoma (RCC)


Find a site near you

Start Over

Investigator Site - Joinville

Joinville, Brazil
0.45miles
  Connect »